Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Endotoxin Testing Market?

In recent times, the endotoxin testing market has been expanding steadily. It’s expected to rise from $2.24 billion in 2024, reaching $2.32 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The notable growth during the historical timeframe was a result of increased demand for biologics and biosimilars, along with an augmented awareness of the essential role that endotoxin testing holds and escalating prevalence of infectious diseases.

What Growth Rate Is Forecasted for the Endotoxin Testing Market by 2029?

In the coming years, the endotoxin testing market is projected to experience robust growth. The market size is expected to reach $2.91 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.8%. The projected growth during this period can be linked to the enlargement of the biopharmaceutical industry, increased funding for research and development in endotoxin testing, and the expansion of global health care. Noteworthy trends during this forecasted period include the innovation of endotoxin detection instruments, the rise in acceptance of endotoxin testing services, and the increased demand for these services.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12932&type=smp

Which Key Companies Are Shaping the Future of the Endotoxin Testing Market?

Major companies operating in the endotoxin testing market are Thermo Fisher Scientific Inc., Merck KGaA, bioMérieux SA., Eurofins Scientific SE, Lonza Group Ltd., WuXi AppTec Co. Ltd., Bio-Rad Laboratories Inc., Maravai LifeSciences Holdings Inc., Cambrex Corporation, GenScript Biotech Corporation, Charles River Laboratories International Inc., Nelson Laboratories LLC, Lifecore Biomedical Inc., Stellar Biotechnologies Inc., Biovision Inc., Associates of Cape Cod Inc., FUJIFILM Wako Pure Chemical Corporation, InvivoGen Inc., Tebu-bio Nv., MatTek Corporation, Microcoat Biotechnologie GmbH, Accelagen Inc., BioAssay Systems LLC, BioThema AB, Hycult Biotech Inc., Pacific Biolabs Inc., Xiamen Bioendo Technology Co. Ltd., Zhanjiang A&C Biological Ltd., Accugen Laboratories Inc.

Which Factors Are Driving Demand in the Endotoxin Testing Industry?

The growth of the endotoxin testing market is expected to be propelled by the increasing instances of infections associated with healthcare. Such infections are those that are not present at the time of hospital admission but are acquired during the course of medical treatment. These are often caused by contamination of medical equipment or procedures, emphasizing the vital importance of stringent testing mechanisms to guarantee patient safety. Through the evaluation of bacterial endotoxin levels in medical instruments, particularly injectable pharmaceutical items and implantable medical devices, endotoxin testing services significantly thwart such infections. For instance, in December 2022, the United Nations International Children’s Emergency Fund (UNICEF) reported that pneumonia took a toll on the lives of over 700,000 children annually, accounting for the largest number of child deaths due to an infectious disease, which is about 2,000 deaths per day. Additionally, in May 2022, the World Health Organization revealed that 24% of patients annually suffer from healthcare-associated sepsis and of those, 52.3% treated in intensive care units die. This highlights the driving role of escalating healthcare-associated infections in the expansion of the endotoxin testing market.

Endotoxin Testing Market Driver: Rising Demand For Biologics Fuels Growth In The Endotoxin Testing Market

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12932&type=smp

How Is the Endotoxin Testing Market Segmented by Several Divisions?

The endotoxin testing market covered in this report is segmented –

1) By Test Type: LAL (Limulus Amebocyte Lysate) Test, Chromogenic Tests, Turbidimetric Tests, Gel Clot Tests, MAT Test, Rabbit Pyrogen Test, Recombinant Factor C (rFC) Assay

2) By Application: Medical Devices, Pharmaceuticals, Packaging, Raw Materials

3) By End-User: Hospitals, Laboratories, Research Institutes

Subsegments:

1) By LAL (Limulus Amebocyte Lysate) Test: Gel Clot LAL Test, Kinetic LAL Test, Endpoint LAL Test

2) By Chromogenic Tests: Chromogenic LAL Test, Chromogenic Factor C Assay

3) By Turbidimetric Tests: Turbidimetric LAL Test, Turbidimetric Factor C Assay

4) By Gel Clot Tests: Gel Clot LAL Test

5) By MAT Test (Monocyte Activation Test): Direct MAT, Indirect MAT

6) By Rabbit Pyrogen Test: Standard Rabbit Pyrogen Test

7) By Recombinant Factor C (rFC) Assay: RFC Assay For Endotoxin Detection

What are the Emerging Market Trends Driving the Growth of the Endotoxin Testing Industry?

Key players in the endotoxin testing market are striving to maintain their market dominance by integrating innovative technology into their operations. One such company is Lonza Group AG, a biotechnology, pharmaceutical and nutrition manufacturing company based in Switzerland. In August 2023, they debuted the Nebula absorbance reader, a state-of-the-art absorbance microplate reader designed for streamlined endotoxin and pyrogen testing. It aligns with Lonza’s most recent WinKQCL software system, enabling data integrity compliance, expediting training, and reducing the validation burden. This means existing users of the WinKQCL software won’t need to familiarize themselves with a new system to leverage the contemporary reader, thereby minimizing training requirements. The Nebula Absorbance Reader is a modern and technologically superior substitution reader that yields results, aligning with those usually recognized with the ELx808 – the industry’s standard absorbance reader that Lorenz has discontinued. It is also proficiently designed to fulfill the demanding specifications of Lonza’s absorbance-based endotoxin assays, including the Lonza PYROGENT 5000 Turbidimetric and Kinetic-QCL Chromogenic Endotoxin Assays.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report

Which Regions Are Driving Growth in the Endotoxin Testing Market?

North America was the largest region in the endotoxin testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endotoxin testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12932

This Report Delivers Insight On:

1. How big is the endotoxin testing market, and how is it changing globally?

2. Who are the major companies in the endotoxin testing market, and how are they performing?

3. What are the key opportunities and risks in the endotoxin testing market right now?

4. Which products or customer segments are growing the most in the endotoxin testing market?

5. What factors are helping or slowing down the growth of the endotoxin testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model